PathologybioRxivPreprint
In situ single-cell analysis of canonical breast cancer biomarkers: phenotypic heterogeneity and implications on response to HER2 targeting agents.
G. Serna, E. Garcia, R. Fasani…·P. G. Nuciforo
The paper analyzes HER2-positive breast cancer tumors at the single-cell level to identify phenotypic heterogeneity and its implications for response to HER2-targeted therapies.
DOI 10.1101/2022.09.21.508826